Technical analysis for Royalty Pharma PLC (RPRX) involves the use of various technical indicators to analyze stock price movements and predict future trends. These indicators are mathematical calculations based on historical price and volume data. They can provide insights into the strength and direction of the stock's trend and help traders make informed investment decisions.

One commonly used technical indicator for RPRX stock is the Relative Strength Index (RSI). This indicator measures the speed and change of price movements and ranges from 0 to 100. A reading above 70 typically indicates an overbought condition, while a reading below 30 suggests an oversold condition. Traders can use the RSI to identify potential buying or selling opportunities.

Royalty Pharma PLC (RPRX) Technical Analysis

Explore Technical Analysis indicators for Royalty Pharma PLC (RPRX) including RSI, ADX, MACD, ROC, STOCHRSI, and WILLR. Gain insights into the stock's performance with our comprehensive analysis. Learn about the company's market trends and make informed investment decisions.

Royalty Pharma PLC (RPRX) Technical Analysis: Indicators, RSI, ADX, MACD, ROC, STOCHRSI, WILLR

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Royalty Pharma PLC

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	75.69	Sell	33.2%
auto_graphMACD	9.35	Neutral	-19.2%
auto_graphCCI	132.14	Sell	36.6%
auto_graphADX	50.02	Neutral	-5.0%
auto_graphATR	6.49	Buy	-
auto_graphWILLR	-4.52	Sell	43.1%
auto_graphROC	50.44	Neutral	13.6%
auto_graphSTOCHRSI	48.17	Neutral	10.9%

Buy	1	-87.50%
Hold	4	-50.00%
Sell	3	-62.50%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Royalty Pharma PLC (RPRX) Technical Analysis

Keep an eye on Royalty Pharma PLC

Frequently Asked Questions

What are the technical signals for Royalty Pharma PLC (RPRX) stock based on the last 30 days?

Take Your Investments to a Whole New Level